Return to site

Cell Counting Market – Top 3 Players and there Market Growth

The growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.

The growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.

Market Size
The global Cell Counting market size is projected to reach USD 700.8 million by 2027 from USD 377.2 million in 2018, at a CAGR of 8.4%.
Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.
“Danaher Corporation was the leading player in the cell counting market and accounted for the largest share in 2017”
The company has a diversified product portfolio, which comprises of a wide range of instruments and consumables. Danaher offers a number of cell counters, flow cytometers, and hematology analyzers along with a wide range of consumables. In 2018, the company launched the DxH 900 hematology analyzer, and in 2017, the company launched two new flow cytometry systems. With a strong portfolio of cell analysis instruments and incessant efforts to develop innovative products, the company is likely to maintain its strong position in this market in the coming years.
“Thermo Fisher was the second-largest market player in the cell counting market in 2017”
The company offers various innovative flow cytometers, cell counters, microplate readers, and spectrophotometers, along with all consumables ranging from reagents, beads & microspheres, to stains and buffers. The company’s FDA and CE Mark-approved products have helped it to further enhance its presence in this market. Furthermore, Thermo Fisher expanded its presence in the US and South Korea in 2016 by opening new GMP facilities. Moreover, the company aims to strengthen its presence in selected geographies in the Asia Pacific region, undertaking various organic and inorganic growth strategies.
We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-
https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly